Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | 0317956-0000 | None | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | 0317956-0000 | None | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | 0317956-0000 | None | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | proglumide | 4922 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | proglumide | 4922 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | proglumide | 4922 | drug-path |
| Taste transduction | R-HSA-162582 | map04742 | proglumide | 4922 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | proglumide | 4922 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | proglumide | 4922 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | proglumide | 4922 | drug-path |
| Asthma | R-HSA-444620 | map05310 | proglumide | 4922 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | proglumide | 4922 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | proglumide | 4922 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | proglumide | 4922 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | proglumide | 4922 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | proglumide | 4922 | drug-path |
| Shigellosis | 0 | map05131 | proglumide | 4922 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | proglumide | 4922 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | proglumide | 4922 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | proglumide | 4922 | drug-path |